Methods for enhancing antibody-induced cell lysis and treating cancer

Details for Australian Patent Application No. 2006216542 (hide)

Owner University of Iowa Research Foundation

Inventors Weiner, George; Hartmann, Gunther

Agent Davies Collison Cave

Pub. Number AU-B-2006216542

Parent 2001270134

Filing date 15 September 2006

Wipo publication date 12 October 2006

Acceptance publication date 30 April 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61P 35/02 (2006.01) Antineoplastic agents

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

5 October 2006 Complete Application Filed

12 October 2006 Application Open to Public Inspection

  Published as AU-B-2006216542

30 April 2009 Application Accepted

  Published as AU-B-2006216542

13 August 2009 Alteration of Name

  The name of the applicant has been altered to University of Iowa Research Foundation; Coley Pharmaceutical GmbH

19 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006216544-Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis

2006216540-Device for post-installation in-situ barrier creation and method of use thereof